The Potential of Optical Coherence Tomography Angiography (OCTA) to Detect Early Cognitive Dysfunction in Diabetic Patients

Active, not recruitingOBSERVATIONAL
Enrollment

210

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

October 30, 2025

Study Completion Date

December 31, 2025

Conditions
Type 2 Diabetes Mellitus Diabetic Retinopathy Cognitive Dysfunction
Interventions
DEVICE

OCT angiography RTVue XR Avanti; Optovue, Inc, Fremont, California, USA

OCTA is a fast, non-invasive, and contactless imaging technique that enables detailed visualization of the retinal microvasculature by tracking erythrocyte movement within blood vessels in real time. It provides layer-by-layer analysis of the retina and choroid without the need for intravenous contrast, significantly reducing patient risk and improving accessibility. Increasing evidence suggests that neurodegenerative and vascular changes precede clinically visible signs of disease, making OCTA a valuable diagnostic tool for early detection of diabetic retinopathy before it can be confirmed through standard fundus examination. The MoCA test includes assessments of executive functions, high-level language abilities, and complex visuospatial tasks, making it suitable for detecting even mild cognitive dysfunction.

Trial Locations (1)

71000

dr Sefic Eye Polyclinic and Optical Studio, Sarajevo

All Listed Sponsors
lead

Dr. Sefic Eye Polylcinic and Optical Studio

OTHER